CapsoVision (CV) EPS (Basic) (2024 - 2025)
CapsoVision (CV) reported EPS (Basic) of -$0.3 for Q4 2025, up 86.89% on a YoY basis from -$0.16 in Q4 2024, and down 75.69% sequentially from -$0.17 in Q3 2025.
CapsoVision (CV) EPS (Basic) (2024 - 2025) Analysis & Trends
CapsoVision (CV) has 2 years of EPS (Basic) data on file, last reported at -$0.3 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Basic) rose 86.89% year-over-year to -$0.3; the trailing twelve-month figure through Dec 2025 stood at -$1.0 (changed N/A YoY), and the FY2025 full-year result was -$1.03, up 89.53% from the prior year.
- EPS (Basic) retreated to -$0.3 in Q4 2025, from -$0.17 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.17 in Q3 2025 to a low of -$2.79 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CapsoVision | 162.07 Mn | 151.95 Mn | 1.95 Mn | -0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.30 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -2.02 |
| Dec 31, 2024 | -2.30 |
| Sep 30, 2024 | -2.79 |
| Jun 30, 2024 | -2.58 |